E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 7/7/2008 in the Prospect News PIPE Daily.

New Issue: MabCure wraps $1.3 million private placement of units

By Devika Patel

Knoxville, Tenn., July 7 - MabCure Inc. said it settled a $1.3 million private placement of units.

The company sold 1.3 million units at $1.00 apiece.

The units each consist of one common share and two warrants. The warrants are exercisable at $1.25 for one year and at $1.25 for two years.

Proceeds will be used for working capital.

Reno, Nev.-based MabCure is a biotechnology company.

Issuer:MabCure Inc.
Issue:Units of one common share and two warrants
Amount:$1.3 million
Units:1.3 million
Price:$1.00
Warrants:Two warrants per unit
Warrant expiration:One year (first warrant), two years (second warrant)
Warrant strike price:$1.25
Settlement date:July 7
Stock symbol:OTCBB: MBCI
Stock price:$1.03 at close July 3

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.